Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU – Get Free Report)’s stock price reached a new 52-week high on Wednesday . The company traded as high as $243.00 and last traded at $235.21, with a volume of 559464 shares traded. The stock had previously closed at $230.01.
Direxion Daily S&P Biotech Bull 3x Shares Price Performance
The company’s 50 day moving average is $188.64 and its 200-day moving average is $173.69.
Hedge Funds Weigh In On Direxion Daily S&P Biotech Bull 3x Shares
Institutional investors and hedge funds have recently made changes to their positions in the business. Halbert Hargrove Global Advisors LLC purchased a new position in shares of Direxion Daily S&P Biotech Bull 3x Shares during the first quarter valued at approximately $166,000. Barclays PLC purchased a new stake in shares of Direxion Daily S&P Biotech Bull 3x Shares in the 4th quarter worth approximately $893,000. Renaissance Technologies LLC grew its stake in shares of Direxion Daily S&P Biotech Bull 3x Shares by 10.6% in the 4th quarter. Renaissance Technologies LLC now owns 22,900 shares of the company’s stock worth $3,650,000 after buying an additional 2,200 shares during the last quarter. Foundations Investment Advisors LLC bought a new position in Direxion Daily S&P Biotech Bull 3x Shares during the 4th quarter valued at approximately $797,000. Finally, SLT Holdings LLC bought a new position in Direxion Daily S&P Biotech Bull 3x Shares during the 4th quarter valued at approximately $797,000.
Direxion Daily S&P Biotech Bull 3x Shares Company Profile
The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.
Featured Articles
- Five stocks we like better than Direxion Daily S&P Biotech Bull 3x Shares
- MDA Space Targets US Defense Market With $620M Acquisition
- Carnival’s Second Quarter: Is the Stock Still Complicated?
- Domino’s Stock Slides to 52-Week Low as Investors Digest CEO Change
- Microsoft Solves AI’s Biggest Bottleneck With Chevron Deal
Receive News & Ratings for Direxion Daily S&P Biotech Bull 3x Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Direxion Daily S&P Biotech Bull 3x Shares and related companies with MarketBeat.com's FREE daily email newsletter.
